{"AllianceGenome": "9208", "HGNC": "9208", "MIM": "124015", "_id": "5447", "_version": 1, "accession": {"genomic": ["AC005067.2", "AC006330.5", "CH471220.1", "CP068271.2", "DQ640499.1", "NC_000007.14", "NC_060931.1", "NG_008930.1"], "protein": ["AAB21814.1", "AAD45961.1", "AAG09798.1", "AAH34277.1", "ABF70199.1", "BAB18572.1", "BAD93111.1", "BAF83218.1", "BAG35442.1", "BAG56734.1", "BAG58850.1", "BAG59240.1", "BAG65317.1", "CAH56151.1", "EAW71777.1", "EAW71778.1", "EAW71779.1", "EAW71780.1", "NP_000932.3", "NP_001354491.2", "NP_001369584.2", "NP_001369586.2", "NP_001369587.2", "NP_001369588.2", "NP_001369591.2", "NP_001382342.1", "P16435.2"], "rna": ["AB051763.1", "AB209874.1", "AF258341.1", "AK129978.1", "AK290529.1", "AK293194.1", "AK296096.1", "AK296639.1", "AK304511.1", "AK312543.1", "BC034277.1", "BG104767.1", "BP244929.1", "BX648619.1", "DA701694.1", "NM_000941.2", "NM_001367562.3", "NM_001382655.3", "NM_001382657.2", "NM_001382658.3", "NM_001382659.3", "NM_001382662.3", "NM_001395413.1", "S90469.1"], "translation": [{"protein": "NP_001369584.2", "rna": "NM_001382655.3"}, {"protein": "BAG59240.1", "rna": "AK296639.1"}, {"protein": "NP_001369588.2", "rna": "NM_001382659.3"}, {"protein": "NP_001369591.2", "rna": "NM_001382662.3"}, {"protein": "NP_000932.3", "rna": "NM_000941.2"}, {"protein": "BAD93111.1", "rna": "AB209874.1"}, {"protein": "NP_001382342.1", "rna": "NM_001395413.1"}, {"protein": "NP_001369586.2", "rna": "NM_001382657.2"}, {"protein": "BAG58850.1", "rna": "AK296096.1"}, {"protein": "AAB21814.1", "rna": "S90469.1"}, {"protein": "AAG09798.1", "rna": "AF258341.1"}, {"protein": "BAF83218.1", "rna": "AK290529.1"}, {"protein": "NP_001354491.2", "rna": "NM_001367562.3"}, {"protein": "BAG35442.1", "rna": "AK312543.1"}, {"protein": "BAG65317.1", "rna": "AK304511.1"}, {"protein": "BAB18572.1", "rna": "AB051763.1"}, {"protein": "BAG56734.1", "rna": "AK293194.1"}, {"protein": "CAH56151.1", "rna": "BX648619.1"}, {"protein": "NP_001369587.2", "rna": "NM_001382658.3"}, {"protein": "AAH34277.1", "rna": "BC034277.1"}]}, "alias": ["CPR", "CYPOR", "P450R"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2022-03-23T19:37:29.312Z", "disease_label": "Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis", "gcep": "Craniofacial Malformations Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0008726", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6275d46a-f005-45f8-b3ec-e9722f8dd39e-2022-03-23T193729.312Z", "sop": "SOP8"}}, "ec": "1.6.2.4", "ensembl": {"gene": "ENSG00000127948", "protein": ["ENSP00000378355", "ENSP00000389409", "ENSP00000389719", "ENSP00000390540", "ENSP00000393527", "ENSP00000395813", "ENSP00000399327", "ENSP00000399409", "ENSP00000399556", "ENSP00000400964", "ENSP00000403494", "ENSP00000404731", "ENSP00000409238", "ENSP00000409881", "ENSP00000412490", "ENSP00000414263", "ENSP00000419970", "ENSP00000516442", "ENSP00000516443", "ENSP00000516444", "ENSP00000516445", "ENSP00000516446"], "transcript": ["ENST00000394893", "ENST00000412064", "ENST00000412521", "ENST00000414186", "ENST00000418341", "ENST00000421059", "ENST00000426184", "ENST00000432753", "ENST00000439269", "ENST00000439297", "ENST00000439963", "ENST00000447222", "ENST00000448410", "ENST00000449920", "ENST00000453773", "ENST00000454934", "ENST00000460892", "ENST00000461988", "ENST00000471238", "ENST00000475509", "ENST00000487247", "ENST00000493973", "ENST00000495770", "ENST00000496888", "ENST00000706544", "ENST00000706545", "ENST00000706546", "ENST00000706547"], "translation": [{"protein": "ENSP00000395813", "rna": "ENST00000453773"}, {"protein": "ENSP00000390540", "rna": "ENST00000439963"}, {"protein": "ENSP00000516442", "rna": "ENST00000706544"}, {"protein": "ENSP00000399409", "rna": "ENST00000448410"}, {"protein": "ENSP00000419970", "rna": "ENST00000461988"}, {"protein": "ENSP00000409881", "rna": "ENST00000421059"}, {"protein": "ENSP00000516443", "rna": "ENST00000706545"}, {"protein": "ENSP00000516444", "rna": "ENST00000706546"}, {"protein": "ENSP00000516445", "rna": "ENST00000706547"}, {"protein": "ENSP00000378355", "rna": "ENST00000394893"}, {"protein": "ENSP00000409238", "rna": "ENST00000412521"}, {"protein": "ENSP00000399327", "rna": "ENST00000414186"}, {"protein": "ENSP00000389409", "rna": "ENST00000432753"}, {"protein": "ENSP00000399556", "rna": "ENST00000449920"}, {"protein": "ENSP00000389719", "rna": "ENST00000418341"}, {"protein": "ENSP00000404731", "rna": "ENST00000412064"}, {"protein": "ENSP00000414263", "rna": "ENST00000454934"}, {"protein": "ENSP00000393527", "rna": "ENST00000447222"}, {"protein": "ENSP00000400964", "rna": "ENST00000426184"}, {"protein": "ENSP00000403494", "rna": "ENST00000439297"}, {"protein": "ENSP00000516446", "rna": "ENST00000475509"}, {"protein": "ENSP00000412490", "rna": "ENST00000439269"}], "type_of_gene": "protein_coding"}, "entrezgene": "5447", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 22.9401064672, "exp_mis": 270.925791845, "exp_syn": 149.674099129, "lof_z": 2.46944957045137, "mis_z": -0.537094019373537, "mu_lof": 1.95323991502e-06, "mu_mis": 2.9208006991e-05, "mu_syn": 1.57313920642e-05, "n_lof": 11.0, "n_mis": 289.0, "n_syn": 158.0, "p_li": 4.33906087150102e-05, "p_null": 0.00896989699569618, "p_rec": 0.990986712395589, "syn_z": -0.421897878743396}, "bp": 2043, "cds_end": 75615799, "cds_start": 75583310, "n_exons": 15, "nonpsych": {"exp_lof": 20.5115601172, "exp_mis": 244.96254224, "exp_syn": 135.218054647, "lof_z": 2.71308934740373, "mis_z": -0.77464220885473, "mu_lof": 1.95323991502e-06, "mu_mis": 2.9208006991e-05, "mu_syn": 1.57313920642e-05, "n_lof": 8.0, "n_mis": 269.0, "n_syn": 146.0, "p_li": 0.00282943739688939, "p_null": 0.00330164204392977, "p_rec": 0.993868920559181, "syn_z": -0.583769472768857}, "nontcga": {"exp_lof": 21.0803889471, "exp_mis": 249.227236528, "exp_syn": 137.675669102, "lof_z": 2.16580438915568, "mis_z": -0.466201648405373, "mu_lof": 1.95323991502e-06, "mu_mis": 2.9208006991e-05, "mu_syn": 1.57313920642e-05, "n_lof": 11.0, "n_mis": 264.0, "n_syn": 151.0, "p_li": 2.2234213376197e-05, "p_null": 0.0226052414471029, "p_rec": 0.977372524339521, "syn_z": -0.719015120706602}, "transcript": "ENST00000461988.1"}, "exons": [{"cdsend": 75986481, "cdsstart": 75953992, "chr": "7", "position": [[75915154, 75915179], [75953988, 75954180], [75972412, 75972461], [75979450, 75979579], [75980338, 75980488], [75981047, 75981172], [75981516, 75981606], [75982223, 75982322], [75983519, 75983636], [75983737, 75983856], [75984776, 75984958], [75985057, 75985207], [75985578, 75985849], [75985922, 75986068], [75986158, 75986241], [75986336, 75986855]], "strand": 1, "transcript": "NM_000941", "txend": 75986855, "txstart": 75915154}, {"cdsend": 75986481, "cdsstart": 75953992, "chr": "7", "position": [[75915154, 75915179], [75915660, 75915767], [75953988, 75954180], [75972412, 75972461], [75979450, 75979579], [75980338, 75980488], [75981047, 75981172], [75981516, 75981606], [75982223, 75982322], [75983519, 75983636], [75983737, 75983856], [75984776, 75984958], [75985057, 75985207], [75985578, 75985849], [75985922, 75986068], [75986158, 75986241], [75986336, 75986855]], "strand": 1, "transcript": "NM_001367562", "txend": 75986855, "txstart": 75915154}, {"cdsend": 75986481, "cdsstart": 75953992, "chr": "7", "position": [[75915154, 75915179], [75953988, 75954180], [75956907, 75956961], [75972412, 75972461], [75979450, 75979579], [75980338, 75980488], [75981047, 75981172], [75981516, 75981606], [75982223, 75982322], [75983519, 75983636], [75983737, 75983856], [75984776, 75984958], [75985057, 75985207], [75985578, 75985849], [75985922, 75986068], [75986158, 75986241], [75986336, 75986855]], "strand": 1, "transcript": "NM_001382655", "txend": 75986855, "txstart": 75915154}, {"cdsend": 75986481, "cdsstart": 75953992, "chr": "7", "position": [[75915154, 75915179], [75922101, 75922200], [75953988, 75954180], [75972412, 75972461], [75979450, 75979579], [75980338, 75980488], [75981047, 75981172], [75981516, 75981606], [75982223, 75982322], [75983519, 75983636], [75983737, 75983856], [75984776, 75984958], [75985057, 75985207], [75985578, 75985849], [75985922, 75986068], [75986158, 75986241], [75986336, 75986855]], "strand": 1, "transcript": "NM_001382657", "txend": 75986855, "txstart": 75915154}, {"cdsend": 75986481, "cdsstart": 75953992, "chr": "7", "position": [[75915154, 75915179], [75946771, 75947244], [75953988, 75954180], [75972412, 75972461], [75979450, 75979579], [75980338, 75980488], [75981047, 75981172], [75981516, 75981606], [75982223, 75982322], [75983519, 75983636], [75983737, 75983856], [75984776, 75984958], [75985057, 75985207], [75985578, 75985849], [75985922, 75986068], [75986158, 75986241], [75986336, 75986855]], "strand": 1, "transcript": "NM_001382658", "txend": 75986855, "txstart": 75915154}, {"cdsend": 75986481, "cdsstart": 75953992, "chr": "7", "position": [[75915154, 75915213], [75953988, 75954180], [75972412, 75972461], [75979450, 75979579], [75980338, 75980488], [75981047, 75981172], [75981516, 75981606], [75982223, 75982322], [75983519, 75983636], [75983737, 75983856], [75984776, 75984958], [75985057, 75985207], [75985578, 75985849], [75985922, 75986068], [75986158, 75986241], [75986336, 75986855]], "strand": 1, "transcript": "NM_001382659", "txend": 75986855, "txstart": 75915154}, {"cdsend": 75986481, "cdsstart": 75953992, "chr": "7", "position": [[75915154, 75915666], [75953988, 75954180], [75972412, 75972461], [75979450, 75979579], [75980338, 75980488], [75981047, 75981172], [75981516, 75981606], [75982223, 75982322], [75983519, 75983636], [75983737, 75983856], [75984776, 75984958], [75985578, 75985849], [75985922, 75986068], [75986158, 75986241], [75986336, 75986855]], "strand": 1, "transcript": "NM_001382662", "txend": 75986855, "txstart": 75915154}], "exons_hg19": [{"cdsend": 75615799, "cdsstart": 75583310, "chr": "7", "position": [[75544472, 75544497], [75583306, 75583498], [75601730, 75601779], [75608768, 75608897], [75609656, 75609806], [75610365, 75610490], [75610834, 75610924], [75611541, 75611640], [75612837, 75612954], [75613055, 75613174], [75614094, 75614276], [75614375, 75614525], [75614896, 75615167], [75615240, 75615386], [75615476, 75615559], [75615654, 75616173]], "strand": 1, "transcript": "NM_000941", "txend": 75616173, "txstart": 75544472}, {"cdsend": 75615799, "cdsstart": 75583310, "chr": "7", "position": [[75544472, 75544497], [75544978, 75545085], [75583306, 75583498], [75601730, 75601779], [75608768, 75608897], [75609656, 75609806], [75610365, 75610490], [75610834, 75610924], [75611541, 75611640], [75612837, 75612954], [75613055, 75613174], [75614094, 75614276], [75614375, 75614525], [75614896, 75615167], [75615240, 75615386], [75615476, 75615559], [75615654, 75616173]], "strand": 1, "transcript": "NM_001367562", "txend": 75616173, "txstart": 75544472}, {"cdsend": 75615799, "cdsstart": 75583310, "chr": "7", "position": [[75544472, 75544497], [75583306, 75583498], [75586225, 75586279], [75601730, 75601779], [75608768, 75608897], [75609656, 75609806], [75610365, 75610490], [75610834, 75610924], [75611541, 75611640], [75612837, 75612954], [75613055, 75613174], [75614094, 75614276], [75614375, 75614525], [75614896, 75615167], [75615240, 75615386], [75615476, 75615559], [75615654, 75616173]], "strand": 1, "transcript": "NM_001382655", "txend": 75616173, "txstart": 75544472}, {"cdsend": 75615799, "cdsstart": 75583310, "chr": "7", "position": [[75544472, 75544497], [75551419, 75551518], [75583306, 75583498], [75601730, 75601779], [75608768, 75608897], [75609656, 75609806], [75610365, 75610490], [75610834, 75610924], [75611541, 75611640], [75612837, 75612954], [75613055, 75613174], [75614094, 75614276], [75614375, 75614525], [75614896, 75615167], [75615240, 75615386], [75615476, 75615559], [75615654, 75616173]], "strand": 1, "transcript": "NM_001382657", "txend": 75616173, "txstart": 75544472}, {"cdsend": 75615799, "cdsstart": 75583310, "chr": "7", "position": [[75544472, 75544497], [75576089, 75576562], [75583306, 75583498], [75601730, 75601779], [75608768, 75608897], [75609656, 75609806], [75610365, 75610490], [75610834, 75610924], [75611541, 75611640], [75612837, 75612954], [75613055, 75613174], [75614094, 75614276], [75614375, 75614525], [75614896, 75615167], [75615240, 75615386], [75615476, 75615559], [75615654, 75616173]], "strand": 1, "transcript": "NM_001382658", "txend": 75616173, "txstart": 75544472}, {"cdsend": 75615799, "cdsstart": 75583310, "chr": "7", "position": [[75544472, 75544531], [75583306, 75583498], [75601730, 75601779], [75608768, 75608897], [75609656, 75609806], [75610365, 75610490], [75610834, 75610924], [75611541, 75611640], [75612837, 75612954], [75613055, 75613174], [75614094, 75614276], [75614375, 75614525], [75614896, 75615167], [75615240, 75615386], [75615476, 75615559], [75615654, 75616173]], "strand": 1, "transcript": "NM_001382659", "txend": 75616173, "txstart": 75544472}, {"cdsend": 75615799, "cdsstart": 75583310, "chr": "7", "position": [[75544472, 75544984], [75583306, 75583498], [75601730, 75601779], [75608768, 75608897], [75609656, 75609806], [75610365, 75610490], [75610834, 75610924], [75611541, 75611640], [75612837, 75612954], [75613055, 75613174], [75614094, 75614276], [75614896, 75615167], [75615240, 75615386], [75615476, 75615559], [75615654, 75616173]], "strand": 1, "transcript": "NM_001382662", "txend": 75616173, "txstart": 75544472}], "generif": [{"pubmed": 11971899, "text": "activation of HIF-1 is modulated by cytochrome P-450 reductase in cell membrane"}, {"pubmed": 12787027, "text": "role of coenzyme binding in regulating interflavin electron transfer in human cytochrome P450 reductase"}, {"pubmed": 15220035, "text": "Molecular pathogenesis of this form of congenital adrenal hyperplasia is caused by mutations in the gene encoding P450 oxidoreductase"}, {"pubmed": 15666840, "text": "POR deficiency is a new disorder of adrenal and gonadal steroidogenesis that affects all microsomal cytochrome P450 enzymes, hence may have important implications for genetic differences in drug metabolism."}, {"pubmed": 16467261, "text": "POR deficiency is a new disease, distinct from the craniosynostosis syndromes caused by FGFR mutations."}, {"pubmed": 16998238, "text": "analysis of FAD binding in the Y459H and V492E Antley-Bixler syndrome mutants of human cytochrome P450 reductase"}, {"pubmed": 17018578, "text": "Antticancer activity of motexafin gadolinium may involve inhibition of this enzyme."}, {"pubmed": 17440066, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17440066, "text": "data suggest that African Americans harbor an allele at the POR locus that may increase breast cancer risk"}, {"pubmed": 17505056, "text": "A287P homozygous patients had preferential inhibition of CYP17A1, whereas Steroid 21-Hydroxylase retained near normal activity."}, {"pubmed": 17580970, "text": "The energetics of 2',5'-ADP binding to the FAD-binding domain of cytochrome P450 reductase were characterized."}, {"pubmed": 17595315, "text": "Mutations R457H and V492E located in the FAD domain of NADPH P450 oxidoreductase (POR) that disrupt electron transfer caused a complete loss of CYP19A1 activity."}, {"pubmed": 17635179, "text": "clinical, structural and functional implications of mutations and polymorphisms in POR"}, {"pubmed": 17827787, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17881660, "text": "TG100435 and TG100855 were interconverted metabolically. FMO3 seem to be the major N-oxidizing enzyme, whereas cytochrome P450 reductase seems to be responsible for the retroreduction reaction."}, {"pubmed": 18216718, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18230729, "text": "The POR gene in a representative population of 842 healthy unrelated individuals in four ethnic groups was sequenced and compared."}, {"pubmed": 18259105, "text": "The prognosis for patients with POR deficiency appears to depend on the severity of the bony malformations and their timely treatment."}, {"pubmed": 18397975, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18397975, "text": "The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency."}, {"pubmed": 18551037, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18559916, "text": "POR deficiency can masquerade clinically as isolated 17,20-lyase deficiency."}, {"pubmed": 18630181, "text": "patients with Antley-Bixler-like skeletal anomalies, but with mutations in the POR gene and disordered steroidogenesis, represent a new disorder called POR deficiency."}, {"pubmed": 18681889, "text": "Experiments using excess NADPH over cytochrome P450 reductase provide evidence that both pH and solvent significantly influence the kinetic exposure of the blue di-semiquinone intermediate, yet the observed rate constants are essentially pH independent."}, {"pubmed": 19161969, "text": "CPR's putative membrane topology indicates that the Q153R and R316W missense mutations found in patients with disordered steroidogenesis are located within the membrane-associated regions."}, {"pubmed": 19258400, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19374516, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19598235, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19744540, "text": "Results describe a model of the structure of human P450 oxidoreductase created by in silico amino acid replacements in the rat POR crystal structure."}, {"pubmed": 19805543, "text": "Data support the formation of P450c17, P450arom, and CPR homodimers and oligomers in lipid bilayers."}, {"pubmed": 19837910, "text": "study describes 4 patients with POR deficiency & characterizes activities of their mutations; all were compound heterozygotes for POR mutations, including 5 novel mutations: L577R, N185K, delE217, and frameshift mutations 1363delC 7 697-698insGAAC"}, {"pubmed": 19858215, "text": "Domain motion in cytochrome P450 reductase: conformational equilibria revealed by NMR and small-angle x-ray scattering."}, {"pubmed": 19884324, "text": "study concludes that compromised FMN binding is the specific molecular defect causing POR deficiency in patients with Y181D mutation and that this defect, in large part, can be overcome in vitro by FMN addition"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20096935, "text": "Results indicate that residues in the C-helix of cytochrome P450 2B6 play a major role in the interaction with NADPH-cytochrome P450 reductase."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20697309, "text": "POR variants affect CYP3A4 activities."}, {"pubmed": 20722625, "text": "Report co-expression of recombinant human CYP2C9 with human cytochrome P450 reductase in protease deficient S. cerevisiae strain at a higher scale yields an enzyme of higher specific activity."}, {"pubmed": 20732302, "text": "mutations in POR found in patients with congenital adrenal hyperplasia may reduce HO-1 activity, potentially influencing heme catabolism in individuals carrying mutant POR alleles."}, {"pubmed": 20844025, "text": "Our results provide in vivo evidence for an important role of POR in regulating drug metabolism and detoxification."}, {"pubmed": 20849814, "text": "report mutations in POR in patients with disordered steroidogenesis/Antley-Bixler syndrome may reduce CYP3A4 activity; POR mutants Y181D, A457H, Y459H, V492E, R616X had over 99% loss of CYP3A4 activity; mutations A287P, C569Y, V608F lost 60-85% activity"}, {"pubmed": 20879989, "text": "kinetic studies of catalytic interaction with CYP3A4 in liposomes; data support model in which 1st electron transfer takes place within relatively stable CPR-CYP3A4 complex then complex dissociates/reforms between 1st & 2nd electron transfers"}, {"pubmed": 20940534, "text": "Cytochrome P450 oxidoreductase genetic variants have different effects on catalysis by CYP2D6 that depend on the substrate being metabolized."}, {"pubmed": 21070833, "text": "POR is probably an important contributor to genetic variation in both steroidogenesis and drug metabolism"}, {"pubmed": 21084761, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 21084761, "text": "we identified 75 genetic variations in the POR gene including 26 novel ones from 235 Japanese subjects. Four novel variations resulted in amino acid substitutions."}, {"pubmed": 21164260, "text": "POR variants may also affect skeletal development and drug metabolism."}, {"pubmed": 21265736, "text": "investigation of influence of domain interfaces on various internal and external electron transfer rates, redox potentials of cofactors (FMN/FAD), and global geometry of the enzyme"}, {"pubmed": 21393444, "text": "the human P450 (cytochrome) oxidoreductase gene transcription is regulated by thyroid hormone receptor beta and Smad3/4"}, {"pubmed": 21655236, "text": "Results reveal unusual biochemical differences between mosquito CPR and the human form in the binding of small molecules that may aid the development of 'smart' insecticides and synergists that selectively target mosquito CPR."}, {"pubmed": 21726529, "text": "this study provides novel insights into the regulation of gap junction function by CYPOR and suggests that Cx43 may play an important role(s) in CYPOR-mediated bone defects seen in patients."}, {"pubmed": 21741353, "text": "human POR mutations, shown to impact P450 activities, also result in varying degrees of diminished HO-1 activity, which may further complicate CYPOR deficiency."}, {"pubmed": 21762695, "text": "Studies indicate that electron transfer in cytochrome P450 reductase is conformationally gated."}, {"pubmed": 21770725, "text": "These data indicate that the POR*28 SNP is associated with additional increases in early tacrolimus dose-requirements in patients carrying a CYP3A5*1 allele."}, {"pubmed": 21843508, "text": "a novel POR mutation P399_E401del in two unrelated Turkish patients with 46,XX disorder of sexual development was found."}, {"pubmed": 21900384, "text": "The results suggest that the SP1 binding sites constitute an essential element of the POR proximal promoter."}, {"pubmed": 21973081, "text": "The data suggested that cytochrome P450 reductase plays a major role in reactive oxygen species generation by liver cells under the basal conditions, but a minimal rike during simulated in vitro ischemia-reperfusion injury."}, {"pubmed": 22162478, "text": "Clinical, biochemical, and genetic findings in a large PORD cohort."}, {"pubmed": 22177374, "text": "POR*28 C > T polymorphism increases 1-hydroxylation of midazolam after intravenous administration. The polymorphism is associated with increased hepatic, but not intestinal, CYP3A activity in healthy Chinese volunteers."}, {"pubmed": 22462747, "text": "Six novel NADPH-P450 oxidoreductase missense variants in Ashkenazi and Moroccan Jewish populations were identified."}, {"pubmed": 22545110, "text": "NADPH cytochrome P450 reductase prevents this translocation and promotes oligomerization of HO-1."}, {"pubmed": 22547083, "text": "POR genetic variants affect CYP2C9 activities. The impact of a POR variant on catalysis varies with the isoform of CYP2C9 and the assay substrate."}, {"pubmed": 23353702, "text": "Structural, enzymatic and clinical implications of the NADPH P450 oxidoreductase mutations linked to newly identified disorders in humans, now categorized as POR deficiency[review]."}, {"pubmed": 23832577, "text": "The role of Cytochrome P450 reductase is to provide electrons to a redox partner, the interactions with cytochrome P450 2D6 (2D6) were investigated and a possible complex structure is suggested."}, {"pubmed": 23911089, "text": "Domain motion is linked closely to the individual steps of the catalytic cycle of cytochrome P450 reductase."}, {"pubmed": 24113216, "text": "Candidate-gene study shows that polymorphisms in PPARalpha and POR might predispose patients being treated with tacrolimus to the development of NODAT after kidney transplantation"}, {"pubmed": 24196959, "text": "although POR expression is a potential biomarker of sensitivity to some HAP, identification of other one-electron reductases responsible for HAP activation is needed for their rational clinical development."}, {"pubmed": 24345815, "text": "results showed that the CYP2C19 and/or P450 oxidoreductase genotypes have an impact on the clearance of clobazam and/or N-desmethylclobazam"}, {"pubmed": 24430948, "text": "Data shows that POR*28 allele was not associated with the lipid-lowering effect of atorvastatin."}, {"pubmed": 24448396, "text": "results show that FMO3 E158K and POR A503V polymorphisms are minor sources of nicotine metabolism variation, insufficient to appreciably alter smoking."}, {"pubmed": 24464600, "text": "POR*28 allele is an important source of CYP2C9 activity variability and combined with CYP2C9 gene poly-morphisms may explain individual variability in the effect of sulfonylureas."}, {"pubmed": 24465960, "text": "Seventeen SNPs of CYP3A5, CYP3A4, COMT, IL-10 and POR were identified."}, {"pubmed": 24491563, "text": "Findings regarding the interaction of NADPH-P450 reductase (NPR) with cellular stress response (CSR) indicated function of NPR in hypoxic response."}, {"pubmed": 24589657, "text": "Reciprocal active site substitutions in CPR (H322A) and MSR (A312H) were created. Interflavin electron transfer was inhibited in CPR H322A and accelerated in MSR A312H."}, {"pubmed": 24642534, "text": "NADPH-cytochrome P450 reductase is regulated by all-trans retinoic acid and by 1,25-dihydroxyvitamin D3 in human acute myeloid leukemia cells."}, {"pubmed": 25196843, "text": "Interactions of HO-2 with CPR and BVR, were evaluated."}, {"pubmed": 25322286, "text": "Results show that combining the CYP3A5*1, POR*28 and CYP3A4*22 genotypes allows partial differentiation of early tacrolimus dose requirements and the time to reach therapeutic target concentrations after transplantation."}, {"pubmed": 25495409, "text": "The ABCB1 was significantly associated with the CDR . CYP3A4*1G and CYP3A5*3 could influence CBZ metabolism, while POR*28 had no effect on it. The EPHX1 were significantly associated with CBZD:CBZE ratio."}, {"pubmed": 25521355, "text": "In children with FH, carriage of POR*28 allele is associated with reduced effect of atorvastatin on TChol and LDLc and therefore identifies FH children that may require higher atorvastatin doses to achieve full therapeutic benefits"}, {"pubmed": 25712184, "text": "We identified seven unreported SNP genetic variations. The p.Pro384Leu variant exhibited reduced enzymatic activities compared with wild-type."}, {"pubmed": 25728647, "text": "Transient kinetic dissection of the reaction of POR with NADPH and the reduction in cytochrome c by POR using stopped-flow techniques revealed defects in individual electron transfer steps mediated by A287P."}, {"pubmed": 25809265, "text": "Study is a thorough structural, dynamic, and thermodynamic characterization of the soluble form of human microsomal CPR using small-angle x-ray scattering and nuclear magnetic resonance spectroscopy under various conditions"}, {"pubmed": 26067485, "text": "This study confirmed that CYP3A5*1 was associated with lower tacrolimus trough concentrations. POR*28 was associated with decreased tacrolimus trough concentrations although the effect was small possibly through enhanced CYP3A4 enzyme activity."}, {"pubmed": 26087061, "text": "electron transfer between mCPR and aromatase"}, {"pubmed": 26123203, "text": "POR A503V might decrease the risk of bladder cancer by reducing its metabolic activity."}, {"pubmed": 26227094, "text": "population pharmacokinetic analysis identified that the combined genotype of CYP3A5-POR was the only covariant for the apparent clearance of tacrolimus"}, {"pubmed": 26297733, "text": "POR is the main determinant of SN30000 sensitivity in 3 different genetic backgrounds. Head and neck squamous cell carcinomas showed heterogeneous POR expression. There may be a relationship between HPV status and hypoxia-activated prodrug sensitivity."}, {"pubmed": 26323597, "text": "Interindividual variability in CYP2C19 activity is due to differences in both CYP2C19 protein content associated with gene diplotypes and the cytochrome P450 oxidoreductase content."}, {"pubmed": 26544874, "text": "POR besides CYP2B6 can influence cyclophosphamide metabolism"}, {"pubmed": 26580670, "text": "the POR g.6593A>G polymorphism significantly influences CYP2B6 activity"}, {"pubmed": 26669712, "text": "P450 (Cytochrome) Oxidoreductase Gene (POR) Common Variant (POR*28) Significantly Alters CYP2C9 Activity in Swedish, But Not in Korean Healthy Subjects"}, {"pubmed": 26829596, "text": "POR*28 does not significantly influence Tac pharmacokinetic parameters."}, {"pubmed": 26969897, "text": "Compound heterozygosity of a paternal submicroscopic deletion and a maternal missense mutation in POR gene: Antley-bixler syndrome phenotype in three sibling fetuses"}, {"pubmed": 27068427, "text": "analysis of mutations and polymorphisms in POR linked to metabolism of steroids and xenobiotics and pathology of P450 oxidoreductase deficiency (PORD)"}, {"pubmed": 27271371, "text": "Suggest that hepatic POR and P450s are coregulated, and that POR plays a complex role in P450-mediated metabolism."}, {"pubmed": 27376429, "text": "Case Report: delayed diagnosis of 46, XY disorder of sex development due to P450 oxidoreductase (POR) deficiency."}, {"pubmed": 27439448, "text": "POR rs2868177 and CYP2B6*6 variants contribute to the interindividual variability in human CYP2B6 activity, which may affect the disposition and interaction of other CYP2B6 substrate drugs"}, {"pubmed": 27461959, "text": "analysis of the role of the active site loop in coenzyme binding and flavin reduction in cytochrome P450 reductase"}, {"pubmed": 27488389, "text": "For the first time, the SNP POR*37 831-35C>T was confirmed as a minor but statistically significant factor associated with inter-individual variation in warfarin maintenance dose in Han Chinese"}, {"pubmed": 27496950, "text": "Current studies demonstrate that, unlike previously described mutations, A287P causes POR deficiency disorder due to conformational instability leading to proteolytic susceptibility in vivo, rather than through an inherent flavin-binding defect."}, {"pubmed": 27660057, "text": "No significant differences in the distribution of haplotypes between cases and controls were detected. In conclusion, this study reveals that four SNPs in the POR gene (rs3823884, rs3898649, rs239953 and rs17685) may affect the susceptibility of smoking cessation in a Chinese Han population."}, {"pubmed": 28000554, "text": "A homodimer model can resolve the conundrum as to how cytochrome P450 oxidoreductase and cytochrome b5 compete for the same binding site on cytochrome P450c17. (Review)"}, {"pubmed": 28094348, "text": "CYP3A5, ABCB1 and two POR genotypes were assessed by real-time PCR."}, {"pubmed": 28592191, "text": "The POR*28 heterozygote appears to be associated with the stable dose of acenocoumarol."}, {"pubmed": 28655775, "text": "To promote intracellular iron flux, an iron chaperone appears to be essential for receiving iron from heme catabolism. Data suggest that PCBP2 competes with CPR for binding HO1; PCBP2 K homology 3 domain is important for HO1/PCBP2 interaction; heme prompts HO1/CPR multimer and decreases HO1/PCBP2 multimer. [PCBP2 = poly(rC) binding protein 2; CPR = cytochrome P450 reductase; HO1 = heme oxidase 1]"}, {"pubmed": 28656666, "text": "genetic association studies in population in Scotland: data suggest, in type 2 diabetes treated with sulfonylureas, 2 SNPs in CYP2C9 (CYP2C9*2, R144C, rs1799853; CYP2C9*3, I359L, rs1057910) are associated with drug-induced hypoglycemia; an SNP in POR (POR*28, A503V, rs1057868) is associated with better response to sulfonylureas. (CYP2C9 = cytochrome P450 family 2 subfamily C member 9; POR = cytochrome p450 oxidoreductase)"}, {"pubmed": 28852004, "text": "Domain motion is intrinsically linked to the functionality of the enzyme, and the authors can define the position of the conformational equilibrium for individual steps in the catalytic cycle."}, {"pubmed": 29135906, "text": "Younger age, POR*28 allele, and CYP3A5*3 allele were associated with higher cyclosporine dosing requirements and lower concentration/dose ratio."}, {"pubmed": 29165687, "text": "POR-BRAF gene fusion is associated with radiation-associated Thyroid Cancer."}, {"pubmed": 29233819, "text": "Both CYP1A2 and CYP2B4 activities were affected by their coexpression in a manner consistent with formation of the high-affinity POR-CYP1A2-CYP2B4 complex."}, {"pubmed": 29323757, "text": "Study provides evidence that CYP-activity by normal urothelium is reliant on the differentiation-dependent expression of POR, thereby defining the CYP-capacity of different neoplastic programs. Further results, POR expression seems to be suppressed in muscle-invasive bladder cancer."}, {"pubmed": 30040022, "text": "Clinical characteristics and CYP3A5/CYP3A4/POR genotypes were collected."}, {"pubmed": 30076541, "text": "Coffee consumption is causally associated with an increased risk of osteoarthritis. SNPs in NCALD, POR, CYP1A1 and NRCAM were identified."}, {"pubmed": 30110125, "text": "A significant correlation between high CYPOR gene expression and shorter recurrence-free survival (RFS), but not overall survival, was found in the cohort of 249 TNBC patients (p = 0.018, HR = 1.77, 95% CI 1.1-2.85), and this correlation was recapitulated in a cohort of 580 basal-like breast cancer patients (p = 0.018, HR = 1.4, 95% CI 1.06-1.86)."}, {"pubmed": 30323313, "text": "The positive influence of mutations in the POR gene on TAC exposure at 3 months after kidney transplantation."}, {"pubmed": 30563285, "text": "Data suggest that the highly flexible hinge of CPR is responsible for the existence of a conformational aggregate of different open CPR conformers enabling electron transfer-interaction with structural varied redox partners."}, {"pubmed": 31669572, "text": "The allelic variants of P450 when present with a variant form of POR may show different activities, and combined effects of variations in the P450 enzymes as well as in the POR should be considered when genetic data are available."}, {"pubmed": 31857256, "text": "Association of POR and PPARalpha polymorphisms with risk of anti-tuberculosis drug-induced liver injury in Western Chinese Han population."}, {"pubmed": 32238417, "text": "Stereoselective Bupropion Hydroxylation by Cytochrome P450 CYP2B6 and Cytochrome P450 Oxidoreductase Genetic Variants."}, {"pubmed": 32725309, "text": "Clinical and genetic analysis of cytochrome P450 oxidoreductase (POR) deficiency in a female and the analysis of a novel POR intron mutation causing alternative mRNA splicing : Overall analysis of a female with POR deficiency."}, {"pubmed": 32820517, "text": "[Clinical and genetic analysis of a pedigree affected with cytochrome P450 oxidoreductase deficiency]."}, {"pubmed": 32826979, "text": "Genetic control of CCL24, POR, and IL23R contributes to the pathogenesis of sarcoidosis."}, {"pubmed": 33011882, "text": "Microsomal reductase activity in patients with thyroid neoplasms."}, {"pubmed": 33321093, "text": "Membrane Damage during Ferroptosis Is Caused by Oxidation of Phospholipids Catalyzed by the Oxidoreductases POR and CYB5R1."}, {"pubmed": 33420418, "text": "An electron transfer competent structural ensemble of membrane-bound cytochrome P450 1A1 and cytochrome P450 oxidoreductase."}, {"pubmed": 33539003, "text": "Cytochrome P450 reductase (POR) as a ferroptosis fuel."}, {"pubmed": 33666875, "text": "POR polymorphisms are associated with 21 hydroxylase deficiency."}, {"pubmed": 33859207, "text": "Biased cytochrome P450-mediated metabolism via small-molecule ligands binding P450 oxidoreductase."}, {"pubmed": 35164791, "text": "The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomics."}, {"pubmed": 35889519, "text": "In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase."}, {"pubmed": 36321415, "text": "POR overexpression induces tamoxifen-resistance in breast cancer through the STAT1/c-Myc pathway."}, {"pubmed": 36951964, "text": "Effect of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of rivaroxaban and edoxaban in patients with nonvalvular atrial fibrillation."}, {"pubmed": 37509119, "text": "Single Mutations in Cytochrome P450 Oxidoreductase Can Alter the Specificity of Human Cytochrome P450 1A2-Mediated Caffeine Metabolism."}, {"pubmed": 37517692, "text": "Allosteric modulation of cytochrome P450 enzymes by the NADPH cytochrome P450 reductase FMN-containing domain."}], "genomic_pos": {"chr": "7", "end": 75986855, "ensemblgene": "ENSG00000127948", "start": 75899200, "strand": 1}, "genomic_pos_hg19": [{"chr": "7", "end": 75616173, "start": 75528518, "strand": 1}, {"chr": "HG1257_PATCH", "end": 75451812, "start": 75364157, "strand": 1}], "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0006805", "qualifier": "involved_in", "term": "xenobiotic metabolic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0009725", "qualifier": "involved_in", "term": "response to hormone"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0022900", "pubmed": [2513880, 10048323], "qualifier": "involved_in", "term": "electron transport chain"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032770", "pubmed": 19448135, "qualifier": "involved_in", "term": "positive regulation of monooxygenase activity"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0090346", "pubmed": 19448135, "qualifier": "involved_in", "term": "cellular organofluorine metabolic process"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005789", "qualifier": "located_in", "term": "endoplasmic reticulum membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "is_active_in", "term": "cytosol"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0016020", "pubmed": 19946888, "qualifier": "located_in", "term": "membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0043231", "pubmed": 9618440, "qualifier": "located_in", "term": "intracellular membrane-bounded organelle"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0003958", "qualifier": "enables", "term": "NADPH-hemoprotein reductase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003958", "pubmed": [2513880, 10048323, 19448135], "qualifier": "enables", "term": "NADPH-hemoprotein reductase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0003958", "qualifier": "enables", "term": "NADPH-hemoprotein reductase activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 21081644, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0010181", "qualifier": "enables", "term": "FMN binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0050660", "qualifier": "enables", "term": "flavin adenine dinucleotide binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0050661", "qualifier": "enables", "term": "NADP binding"}]}, "homologene": {"genes": [[3702, 829144], [4530, 4345047], [4530, 4347838], [4896, 2541038], [4932, 856438], [5141, 3880583], [6239, 175710], [7227, 33883], [7955, 568202], [8364, 100486781], [9031, 417520], [9544, 715888], [9598, 463481], [9606, 5447], [9615, 489816], [9913, 532512], [10090, 18984], [10116, 29441], [28985, 2893137], [33169, 4618441], [318829, 2683239]], "id": 725}, "interpro": [{"desc": "Oxidoreductase FAD/NAD(P)-binding", "id": "IPR001433", "short_desc": "OxRdtase_FAD/NAD-bd"}, {"desc": "Flavoprotein pyridine nucleotide cytochrome reductase", "id": "IPR001709", "short_desc": "Flavoprot_Pyr_Nucl_cyt_Rdtase"}, {"desc": "Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding", "id": "IPR003097", "short_desc": "CysJ-like_FAD-binding"}, {"desc": "FAD-binding domain, ferredoxin reductase-type", "id": "IPR017927", "short_desc": "FAD-bd_FR_type"}, {"desc": "Riboflavin synthase-like beta-barrel", "id": "IPR017938", "short_desc": "Riboflavin_synthase-like_b-brl"}, {"desc": "NADPH-cytochrome p450 reductase, FAD-binding, alpha-helical domain superfamily", "id": "IPR023173", "short_desc": "NADPH_Cyt_P450_Rdtase_alpha"}, {"desc": "Ferredoxin-NADP reductase (FNR), nucleotide-binding domain", "id": "IPR039261", "short_desc": "FNR_nucleotide-bd"}, {"desc": "Flavodoxin-like", "id": "IPR001094", "short_desc": "Flavdoxin-like"}, {"desc": "Flavodoxin/nitric oxide synthase", "id": "IPR008254", "short_desc": "Flavodoxin/NO_synth"}, {"desc": "NADPH-cytochrome P450 reductase", "id": "IPR023208", "short_desc": "P450R"}, {"desc": "Flavoprotein-like superfamily", "id": "IPR029039", "short_desc": "Flavoprotein-like_sf"}], "ipi": ["IPI00470467", "IPI00852905", "IPI00908675", "IPI00910178", "IPI00924439", "IPI00925752", "IPI00926806", "IPI00973067", "IPI01010631"], "map_location": "7q11.23", "name": "cytochrome p450 oxidoreductase", "other_names": ["NADPH--cytochrome P450 reductase", "NADPH--hemoprotein reductase", "NADPH-dependent cytochrome P450 reductase", "P450 (cytochrome) oxidoreductase"], "pantherdb": {"HGNC": "9208", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "97744", "ortholog_type": "LDO", "panther_family": "PTHR19384", "taxid": 10090, "uniprot_kb": "P37040"}, {"RGD": "68335", "ortholog_type": "LDO", "panther_family": "PTHR19384", "taxid": 10116, "uniprot_kb": "P00388"}, {"Ensembl": "ENSGALG00000002053", "ortholog_type": "LDO", "panther_family": "PTHR19384", "taxid": 9031, "uniprot_kb": "F1P2T2"}, {"ZFIN": "ZDB-GENE-050809-121", "ortholog_type": "O", "panther_family": "PTHR19384", "taxid": 7955, "uniprot_kb": "F1Q7F3"}, {"ZFIN": "ZDB-GENE-030131-5767", "ortholog_type": "LDO", "panther_family": "PTHR19384", "taxid": 7955, "uniprot_kb": "F8W4Z6"}, {"WormBase": "WBGene00001262", "ortholog_type": "LDO", "panther_family": "PTHR19384", "taxid": 6239, "uniprot_kb": "Q09590"}, {"FlyBase": "FBgn0015623", "ortholog_type": "LDO", "panther_family": "PTHR19384", "taxid": 7227, "uniprot_kb": "Q27597"}, {"SGD": "S000001084", "ortholog_type": "LDO", "panther_family": "PTHR19384", "taxid": 4932, "uniprot_kb": "P16603"}, {"PomBase": "SPBC29A10.01", "ortholog_type": "LDO", "panther_family": "PTHR19384", "taxid": 4896, "uniprot_kb": "P36587"}, {"dictyBase": "DDB_G0269912", "ortholog_type": "LDO", "panther_family": "PTHR19384", "taxid": 352472, "uniprot_kb": "Q55CT1"}, {"TAIR": "2121894", "ortholog_type": "O", "panther_family": "PTHR19384", "taxid": 3702, "uniprot_kb": "Q9SB48"}, {"TAIR": "2128951", "ortholog_type": "LDO", "panther_family": "PTHR19384", "taxid": 3702, "uniprot_kb": "Q9SUM3"}], "uniprot_kb": "P16435"}, "pathway": {"biocarta": {"id": "arenrf2pathway", "name": "oxidative stress induced gene expression via nrf2"}, "humancyc": [{"id": "PWY-6061", "name": "bile acid biosynthesis, neutral pathway"}, {"id": "PWY-6076", "name": "1,25-dihydroxyvitamin D<sub>3</sub> biosynthesis"}, {"id": "PWY-6398", "name": "melatonin degradation I"}, {"id": "PWY-6402", "name": "superpathway of melatonin degradation"}, {"id": "PWY66-401", "name": "superpathway of tryptophan utilization"}], "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-211859", "name": "Biological oxidations"}, {"id": "R-HSA-211897", "name": "Cytochrome P450 - arranged by substrate type"}, {"id": "R-HSA-211945", "name": "Phase I - Functionalization of compounds"}], "smpdb": {"id": "SMP00650", "name": "Doxorubicin Metabolism Pathway"}, "wikipathways": {"id": "WP43", "name": "Oxidation by Cytochrome P450"}}, "pdb": ["1B1C", "3FJO", "3QE2", "3QFC", "3QFR", "3QFS", "3QFT", "5EMN", "5FA6"], "pfam": ["PF00175", "PF00667", "PF00258"], "pharmgkb": "PA33532", "pharos": {"target_id": 2858, "tdl": "Tbio"}, "pir": "A33421", "prosite": ["PS50902", "PS51384"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF254451", "relationship": "is"}, {"id": "GNF254452", "relationship": "is"}, {"id": "GNF254453", "relationship": "is"}, {"id": "GNF254454", "relationship": "is"}], "GNF_hs-Origene": [{"id": "GNF037338", "relationship": "similar to"}, {"id": "GNF046750", "relationship": "is"}, {"id": "GNF047473", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF087087", "relationship": "is"}, {"id": "GNF087088", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054496", "relationship": "is"}, {"id": "GNF074642", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF068713", "relationship": "is"}, {"id": "GNF068714", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF011489", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF235037", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF094915", "relationship": "is"}, {"id": "GNF134572", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000007.14", "NC_060931.1", "NG_008930.1"], "protein": ["NP_000932.3", "NP_001354491.2", "NP_001369584.2", "NP_001369586.2", "NP_001369587.2", "NP_001369588.2", "NP_001369591.2", "NP_001382342.1"], "rna": ["NM_000941.2", "NM_001367562.3", "NM_001382655.3", "NM_001382657.2", "NM_001382658.3", "NM_001382659.3", "NM_001382662.3", "NM_001395413.1"], "translation": [{"protein": "NP_001369591.2", "rna": "NM_001382662.3"}, {"protein": "NP_001382342.1", "rna": "NM_001395413.1"}, {"protein": "NP_001369584.2", "rna": "NM_001382655.3"}, {"protein": "NP_001369587.2", "rna": "NM_001382658.3"}, {"protein": "NP_001369586.2", "rna": "NM_001382657.2"}, {"protein": "NP_001354491.2", "rna": "NM_001367562.3"}, {"protein": "NP_001369588.2", "rna": "NM_001382659.3"}, {"protein": "NP_000932.3", "rna": "NM_000941.2"}]}, "reporter": {"HG-U133_Plus_2": "208928_at", "HG-U95Av2": "858_at", "HTA-2_0": "TC07000477.hg.1", "HuEx-1_0": ["3009229", "3009266", "3009293"], "HuGene-1_1": "8133670", "HuGene-2_1": "17047411"}, "retired": 96440, "summary": "This gene encodes an endoplasmic reticulum membrane oxidoreductase that is essential for multiple metabolic processes, including reactions catalyzed by cytochrome P450 proteins for metabolism of steroid hormones, drugs and xenobiotics. The encoded protein has a flavin adenine dinucleotide (FAD)-binding domain and a flavodoxin-like domain which bind two cofactors, FAD and FMN, that allow it to donate electrons directly from NADPH to all microsomal P450 enzymes. Mutations in this gene cause a complex set of disorders, including apparent combined P450C17 and P450C21 deficiency, amenorrhea and disordered steroidogenesis, congenital adrenal hyperplasia and Antley-Bixler syndrome, that resemble those caused by defects in steroid metabolizing enzymes such as aromatase, 21-hydroxylase, and 17 alpha-hydroxylase. [provided by RefSeq, Aug 2020].", "symbol": "POR", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1335232"}, "unigene": "Hs.354056", "uniprot": {"Swiss-Prot": "P16435", "TrEMBL": ["A0A8V8NVY2", "A0A9L9PY49", "A0A8V8NKH1", "H0Y4R2", "A0A9L9PXL8", "A0A9L9PXN4", "E7EWU0", "C9JU80", "A0A8V8NVX2", "C9JDE2", "A0A8V8NLF0", "A0A8V8NRY5", "A0A8V8PBF2", "A0A8V8P672", "C9JQ78", "A0A8V8P1G2", "E7EMD0", "A0A8V8NE24"]}, "wikipedia": {"url_stub": "Cytochrome P450 reductase"}}